Life sciences tools company Agilent Technologies (NYSE:A) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up ...

Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.68 billion for the first quarter ended Jan. 31, 2025, ...

Agilent Technologies (A) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.29 per share a year ago. These ...

Medical equipment maker Agilent lowered its annual revenue forecast on Wednesday, as it expects soft demand for its medical tools and equipment from smaller biotech companies.

尽管第一季度业绩超预期，但Agilent 2025财年的展望令投资者失望。公司预计全年营收在$6.68 billion至$6.76 billion之间，低于分析师预期的$6.82 billion。调整后每股收益指引为$5.54至$5.61，其中值也低于分析师一致预期的$5.57。

Agilent Technologies lowered its fiscal 2025 outlook, as profit narrowed in its fiscal first quarter. The laboratory-supply and services company on Wednesday said it now expects revenue of $6.68 ...

Reports Q1 revenue $1.68B, consensus $1.67B. “The Agilent (A) team delivered better than our expectations in Q1. As a result of a solid start ...

SANTA CLARA, Calif. - Agilent Technologies Inc. (NYSE: A) reported better-than-expected first-quarter earnings and revenue but saw its shares tumble 4.8% after hours as the company’s full-year ...

The Santa Clara, California-based firm said that its diagnostics and life sciences revenues rose 4 percent year over year.

Stocks were mixed Wednesday after President Donald Trump threatened to impose a 25% tax on imports from Europe. The Nasdaq ...

The Denver-Boulder metro life sciences market is showing growth in real estate deals and venture capital, but it is ...

UAE investment platform 2PointZero is targeting a stock market listing in Abu Dhabi this year, CEO Mariam bint Mohammed ...